🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screenerTry Stock Screener

France to vote against EU licence extension for weed-killer glyphosate

Published 26/11/2017, 13:00
© Reuters.  France to vote against EU licence extension for weed-killer glyphosate
MON
-

PARIS (Reuters) - France will vote against a five-year extension of the licence for weed-killer glyphosate that the European Commission will propose on Monday, a junior French environment minister said.

The decision makes renewal more difficult for the product, which the U.N. health agency (WHO) has said causes cancer. Glyphosate is a key ingredient in Monsanto Co's (N:MON) top-selling weed-killer Roundup.

"The Commission will put one single proposition on the table on Monday: renewing glyphosate (licence) for five years. In view of the risks, France will oppose this proposition and vote against it," Brune Poirson said in an editorial in French Sunday newspaper Journal du Dimanche.

Fourteen out of 28 countries voted in favour of extending the licence when the EU voted on the issue on Nov. 9 with nine against and five abstentions. Under EU rules, 16 favourable votes are needed as a "qualified majority" for renewal before authorization expires on Dec. 15.

The Commission said after the Nov. 9 vote it would resubmit the proposal at the end of the month.

Glyphosate has been used by farmers for more than 40 years but its use was cast in doubt when WHO's cancer agency said in 2015 it probably causes cancer. The European Chemical Agency said in March this year, however, there was no evidence linking it to cancer in humans.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.